NDAINJECTIONINJECTABLE
Lifecycle
Pre-Launch
Clinical Trials
1
Data completeness
3/8 — Basic
HYDROXYPROGESTERONE CAPROATE (hydroxyprogesterone caproate) by Aspen Surgical is clinical pharmacology hydroxyprogesterone is a potent, long-acting, progestational steroid ester which transforms proliferative endothelium into secretory endothelium, induces mammary gland duct development, and inhibits the production and/or release of gonadotropic hormone; it also shows slight estrogenic, androgenic, or corticoid effects as well, but should not be relied upon for these effects.
Drug data last refreshed 4h ago · AI intelligence enriched 7h ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
Hydroxyprogesterone caproate is a long-acting progestational steroid ester administered via intramuscular injection. It transforms endometrial tissue, induces mammary gland development, and inhibits gonadotropic hormone release. The drug is primarily indicated for advanced adenocarcinoma of the uterine corpus, where doses of 1,000 mg or higher often induce regressive changes.
$0.020BPart D
Pre-LaunchEarly-stage product with minimal current market penetration; launch team will be small and focused on establishing market entry and clinical adoption.
Mechanism of Action
CLINICAL PHARMACOLOGY Hydroxyprogesterone is a potent, long-acting, progestational steroid ester which transforms proliferative endothelium into secretory endothelium, induces mammary gland duct development, and inhibits the production and/or release of gonadotropic hormone; it also shows slight…
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Worked on HYDROXYPROGESTERONE CAPROATE at Aspen Surgical? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.